Cory Sindelar - Feb 10, 2022 Form 4 Insider Report for CALIX, INC (CALX)

Role: Chief Financial Officer
Signature: /s/ Tom Gemetti as Attorney-in-Fact for Cory Sindelar
Stock symbol: CALX
Transactions as of: Feb 10, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/11/2022, 03:19 PM
Previous filing: Nov 29, 2021
Next filing: Feb 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CALX	Stock Option (right to buy)	Award	$0	+77.7K		$0.00	77.7K	Feb 10, 2022	Common Stock	77.7K	$36.74	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 11, 2021, the reporting person was awarded a performance-based nonqualified stock option grant covering 80,000 shares of common stock. On February 10, 2022, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 97.1% of the grant had been achieved, resulting in a nonqualified stock option award of 77,680 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 11, 2022; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 11, 2022.

Content

On February 11, 2021, the reporting person was awarded a performance-based nonqualified stock option grant covering 80,000 shares of common stock. On February 10, 2022, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 97.1% of the grant had been achieved, resulting in a nonqualified stock option award of 77,680 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 11, 2022; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 11, 2022.